>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Brookline Bancorp (BRKL) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $14.50
    • Macerich (MAC) upgraded to Neutral from Underperform at Mizuho; tgt raised to $22
    • Merck (MRK) upgraded to Buy from Hold at HSBC Securities; tgt $130
    • New Fortress Energy (NFE) upgraded to Hold from Sell at Deutsche Bank; tgt $11
    • Pinnacle West (PNW) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $101
    • Pure Storage (PSTG) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $76
    • Shore Bancshares (SHBI) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $20
    • Trimble (TRMB) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $92
  • Downgrades:
    • ACM Research (ACMR) downgraded to Hold from Buy at Needham
    • Alector (ALEC) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $1
    • DTE Energy (DTE) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Entergy (ETR) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • First Citizens BancShares (FCNCA) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $2500
    • First National (FXNC) downgraded to Neutral from Buy at Janney
    • Hanmi Financial (HAFC) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $29
    • IPG Photonics (IPGP) downgraded to Neutral from Buy at Northcoast
    • MSC Industrial (MSM) downgraded to Equal-Weight from Overweight at Stephens; tgt $85
    • M&T Bank (MTB) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $223.50
    • Novartis AG (NVS) downgraded to Reduce from Hold at HSBC Securities
    • Pinnacle Finl (PNFP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $135
    • Transportadora de Gas del Sur (TGS) downgraded to Neutral from Outperform at Santander
    • YPF Soc. Anonima (YPF) downgraded to Neutral from Buy at UBS; tgt raised to $38
  • Others:
    • Abivax SA (ABVX) initiated with a Mkt Outperform at JMP Securities; tgt $33
    • Absci Corporation (ABSI) initiated with a Buy at JonesResearch
    • Align Tech (ALGN) initiated with an Outperform at Mizuho; tgt $295
    • Bitfarms (BITF) initiated with a Buy at Alliance Global Partners; tgt $6
    • Cardinal Health (CAH) resumed with an Outperform at Mizuho; tgt $139
    • Cencora (COR) resumed with an Outperform at Mizuho; tgt $280
    • Coherent (COHR) initiated with a Buy at Jefferies; tgt $135
    • Coya Therapeutics (COYA) initiated with a Buy at D. Boral Capital; tgt $15
    • Dentsply Sirona (XRAY) initiated with a Neutral at Mizuho; tgt $21
    • Doximity (DOCS) initiated with a Neutral at Mizuho; tgt $55
    • eHealth (EHTH) initiated with a Neutral at UBS; tgt $5.50
    • Envista (NVST) initiated with an Underperform at Mizuho; tgt $20
    • Everus (ECG) initiated with an Outperform at Oppenheimer; tgt $70
    • Gen Digital (GEN) initiated with a Buy at UBS; tgt $36
    • Generac (GNRC) initiated with a Equal Weight at Barclays; tgt $189
    • GE Vernova (GEV) initiated with an Outperform at Wolfe Research; tgt $403
    • GoodRx (GDRX) initiated with a Neutral at Mizuho; tgt $5
    • HealthEquity (HQY) initiated with an Outperform at Mizuho; tgt $126
    • Henry Schein (HSIC) initiated with a Neutral at Mizuho; tgt $75
    • Huntington Banc (HBAN) resumed with an Overweight at JP Morgan; tgt raised to $20
    • LifeMD (LFMD) initiated with a Neutral at Mizuho; tgt $7
    • McKesson (MCK) resumed with a Neutral at Mizuho; tgt $630
    • Patterson Companies (PDCO) initiated with a Neutral at Mizuho; tgt $23
    • Solventum Corporation (SOLV) initiated with a Neutral at Mizuho; tgt $70
    • Structure Therapeutics (GPCR) initiated with a Buy at H.C. Wainwright; tgt $80
    • Talen Energy (TLN) initiated with a Buy at Daiwa Securities; tgt $248
    • Talkspace (TALK) initiated with an Outperform at Mizuho; tgt $5
    • Veeva Systems (VEEV) initiated with an Outperform at Mizuho; tgt $275
    • Vigil Neuroscience (VIGL) initiated with an Outperform at William Blair